Clinical Trial

Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to use a two arms randomized clinical trial study to evaluate the effectiveness of the effective constituent of Mukbang in helping children with cancer hospitalized for radiotherapy and chemotherapy to improve their appetite, nutritional status and quality of life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-19.
Status change: Not Yet Recruiting → Recruiting 2025-07-31
Trial Details
NCT Number NCT05922553
Lead Sponsor Wei XIA, PhD
Conditions Children With Cancer
Enrollment 124 participants
Start Date 2024-12-16
Primary Completion 2026-03 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-08-06